Safety and Efficacy of Eltrombopag in Patients Undergoing Cord Blood or Haploidentical Bone Marrow Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Eltrombopag (Primary)
- Indications Bone marrow transplant rejection; Cord blood stem cell transplant rejection
- Focus Therapeutic Use
- 11 May 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Jul 2017 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.
- 11 Jul 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2019.